Last update 16 Aug 2025

mRNA-1283.529

Overview

Basic Info

Drug Type
Prophylactic vaccine, mRNA vaccine
Synonyms
next generation mRNA booster monovalent vaccine(ModeRNA), mRNA-1283.529
Target
SARS-CoV-2 S protein
Action
modulators
Mechanism
SARS-CoV-2 S protein modulators(SARS-CoV-2 S protein modulators)
Therapeutic Areas
Infectious DiseasesRespiratory Diseases
Active Indication-
Inactive Indication
COVID-19
Originator Organization
Moderna, Inc.Moderna, Inc.
Active Organization-
Inactive Organization
ModernaTX, Inc.
License Organization-
Drug Highest PhasePendingPhase 2
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with mRNA-1283.529
NCT05137236
/ CompletedPhase 2
A Phase 2A, Randomized, Stratified, Observer-Blind Study to Evaluate the Immunogenicity and Safety of mRNA-1283 Vaccine Boosters for SARS-CoV-2
100 Clinical Results associated with mRNA-1283.529
Login to view more data
100 Translational Medicine associated with mRNA-1283.529
Login to view more data
100 Patents (Medical) associated with mRNA-1283.529
Login to view more data
100 Deals associated with mRNA-1283.529
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
COVID-19Phase 2
United States
ModernaTX, Inc.
06 Dec 2021
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free